Axcella Health Stock Forecast, Price & News

Axcella Health (NASDAQ:AXLA) Frequently Asked Questions

Is Axcella Health a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last twelve months. There are currently 1 sell rating, 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Axcella Health stock.
View analyst ratings for Axcella Health or view top-rated stocks.

How has Axcella Health's stock been impacted by COVID-19 (Coronavirus)?

Axcella Health's stock was trading at $3.32 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AXLA shares have decreased by 45.2% and is now trading at $1.82.
View which stocks have been most impacted by COVID-19.

When is Axcella Health's next earnings date?

Axcella Health is scheduled to release its next quarterly earnings announcement on Wednesday, March 16th 2022.
View our earnings forecast for Axcella Health.

How were Axcella Health's earnings last quarter?

Axcella Health Inc. (NASDAQ:AXLA) announced its earnings results on Wednesday, November, 10th. The company reported ($0.41) EPS for the quarter, beating the consensus estimate of ($0.45) by $0.04.
View Axcella Health's earnings history.

What price target have analysts set for AXLA?

8 brokerages have issued 1 year price targets for Axcella Health's shares. Their forecasts range from $5.00 to $14.00. On average, they anticipate Axcella Health's stock price to reach $9.67 in the next year. This suggests a possible upside of 431.1% from the stock's current price.
View analysts' price targets for Axcella Health or view top-rated stocks among Wall Street analysts.

Who are Axcella Health's key executives?

Axcella Health's management team includes the following people:

• William R. Hinshaw, President, Chief Executive Officer & Director
• Tony Tramontin, Chief Scientific Officer, Senior VP-R&D
• Margaret Koziel, Chief Medical Officer & Senior Vice President
• Alison Schecter, President-Research & Development
• Paul Fehlner, Secretary, Chief Legal Officer & Senior VP

What is Bill Hinshaw's approval rating as Axcella Health's CEO?

3 employees have rated Axcella Health CEO Bill Hinshaw on Glassdoor.com. Bill Hinshaw has an approval rating of 100% among Axcella Health's employees. This puts Bill Hinshaw in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Axcella Health's key competitors?

Some companies that are related to Axcella Health include ADMA Biologics (ADMA), Cardiff Oncology (CRDF), Compass Therapeutics (CMPX), Compass Therapeutics (CMPX), Compugen (CGEN), Environmental Impact Acquisition (ENVI), Genfit (GNFT), Ambrx Biopharma (AMAM), SQZ Biotechnologies (SQZ), Jasper Therapeutics (JSPR), Acumen Pharmaceuticals (ABOS), Codiak BioSciences (CDAK), Surface Oncology (SURF), Harpoon Therapeutics (HARP) and aTyr Pharma (LIFE).
View all of AXLA's competitors.

What other stocks do shareholders of Axcella Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Evofem Biosciences (EVFM), ADMA Biologics (ADMA), Coty (COTY), Energy Transfer (ET), Myovant Sciences (MYOV), NVIDIA (NVDA), Pfizer (PFE) and Moderna (MRNA).

When did Axcella Health IPO?

(AXLA) raised $76 million in an initial public offering (IPO) on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink served as the underwriters for the IPO.

What is Axcella Health's stock symbol?

Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."

How do I buy shares of Axcella Health?

Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axcella Health's stock price today?

One share of AXLA stock can currently be purchased for approximately $1.82.

How much money does Axcella Health make?

Axcella Health has a market capitalization of $70.83 million. The company earns $-56.53 million in net income (profit) each year or ($1.63) on an earnings per share basis.

How many employees does Axcella Health have?

Axcella Health employs 59 workers across the globe.

What is Axcella Health's official website?

The official website for Axcella Health is www.axcellahealth.com.

Where are Axcella Health's headquarters?

Axcella Health is headquartered at 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139.

How can I contact Axcella Health?

Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at (857) 320-2200, via email at [email protected], or via fax at 617-441-6243.